Civic Intelligence

International Foxp1 Foundation

EIN 85-4079051 • 501(c)3 • Mendenhall, PA

Profile

Support those impacted by foxp1 syndrome and raise funds for further research into foxp1 syndrome and possible treatments.

PO Box 846Mendenhall, PA 19357

www.foxp1.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

60th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2024

Liabilities / Revenue

62nd percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2024

Net Margin

83rd percentile

33%

Higher net margin than 83% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Top Officer Pay

81st percentile

$0

Higher top officer pay than 81% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2024

Asset Growth

89th percentile

70%

Faster asset growth than 89% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Revenue Growth

93rd percentile

133%

Faster revenue growth than 93% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / Assets60th percentile

Assets

Up

$291,034

Up $119,624 (+70%) from 2023

Liabilities

Flat

$0

Flat from 2023

Net Assets

Up

$291,034

Up $119,624 (+70%) from 2023

Operations
Liabilities / Revenue62nd percentileNet Margin83rd percentile

Revenue

Up

$339,333

Up $193,949 (+133%) from 2023

Expenses

Up

$229,022

Up $179,170 (+359%) from 2023

Net Income

Up

$110,311

Up $14,779 (+15%) from 2023

Trend Graphs

Balance Sheet Trend

Asset Growth89th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$300K$200K$100K$0Assets 2023: $171,410Liabilities 2023: $0Net Assets 2023: $171,4102023Assets 2024: $291,034Liabilities 2024: $0Net Assets 2024: $291,0342024

Highlighted filing

2024

Assets$291,034
Liabilities$0
Net Assets$291,034
Open 2024 Filing

Operations Trend

Revenue Growth93rd percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$400K$300K$200K$100K$0Revenue 2023: $145,384Expenses 2023: $49,852Net Income 2023: $95,5322023Revenue 2024: $339,333Expenses 2024: $229,022Net Income 2024: $110,3112024

Highlighted filing

2024

Revenue$339,333
Expenses$229,022
Net Income$110,311
Open 2024 Filing

Filings

Most recent year

2024 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$291,034
Liabilities
$0
Net assets
$291,034
Revenue
$339,333
Expenses
$229,022
Net income
$110,311
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024Detailed filing. Detailed filing data is available for this year.$2.91$0.00$2.91$3.39$2.29$1.10
2023Detailed filing. Detailed filing data is available for this year.$1.71$0.00$1.71$1.45$0.50$0.96
Latest Filing Detail
Jump To
Filing Snapshot
Filing Period
Jan 1, 2024 to Dec 31, 2024
Signed
May 13, 2025
Return Version
2024v5.1
Gross Receipts
$349,913
Mission and Program Overview

Mission

Support those impacted by foxp1 syndrome and raise funds for further research into foxp1 syndrome and possible treatments.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$171,410$291,034▲ $119,624
Rtn Earn Endowment Incm Other Fnds$171,410$291,034▲ $119,624
Pd in Cap Srpls Land Bldg Eqp Fund$0$0→ $0
Cap Stk Tr Prin Current Funds$0$0→ $0
Total Assets$171,410$291,034▲ $119,624
Liabilities
Total Liabilities$0$0→ $0
Net Assets / Fund Balance
Total Net Assets Fund Balance$171,410$291,034▲ $119,624
Total Liabilities and Net Assets / Fund Balance$171,410$291,034▲ $119,624
Compensation and Service Providers
Top Officer Pay81st percentile

Board Members and Trustees

NameTitle
Adam GellerCo-founder & Co-president
Karl WhitneyCo-founder & Co-president
Katharine MoweryVice President
Caroline DuryMember at Large
Cheryl RichtMember at Large
Gail ClarkMember at Large
Samit DasguptaMember at Large
Chris SullivanSecretary
Adam MoweryTreasurer
Revenue and Support

Revenue Composition

Contributions and Grants
$339,208
Program Service Revenue
$0
Investment Income
$125
Other Revenue
$0
All Other Contributions
$339,208
Change in Net Assets
$110,311
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Grants and Similar Amounts Paid$185,674
Other Expenses$43,348
Total Fundraising Expense$5,636
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Grants to Domestic Orgs$123,274--$123,274
Foreign Grants$62,400--$62,400
Travel-$19,488-$19,488
Fees for Services Other-$6,783-$6,783
Advertising-$3,737-$3,737
Fees for Services Accounting-$1,740-$1,740
Insurance-$1,253-$1,253
Conferences and Meetings-$507-$507
Office Expenses-$381-$381
Other Expenses-$74$5,636$74
Total Functional Expenses$185,674$37,712$5,636$229,022
International Activity

Grant and Assistance Recipients

RecipientLocationCategoryPurposeAmount
Genevieve Konopka and Jay Gibson Ut Southwestern Med CenterDallas, TX501(c)(3)Research on Functional Restoration of Foxp1 Haploinsufficiency Using Aav-mediated Gene Rescue in the Brain$73,274
Joseph Buxbaum Seaver Autism Institute Mt Sinai HospitalNew York, NY501(c)(3)Research on Three-dimensional Organoid Model of Foxp1 Syndrome$50,000

International Summary

Offices
0
Employees
0
Spending
$62,400

International Compliance

Foreign grant records maintained
Yes
Activity in boycott countries
No
Foreign corporation ownership
No
Foreign partnership interest
No
Interest in foreign trust
No
Passive foreign investment company interest
No
Transfers to foreign corporations
No

International Activities

RegionActivityServicesOfficesEmployeesSpending
Europe (including Iceland & Greenland)Grant to Recipients Located in the Region-00$62,400
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
Yes
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section A, Line 2

“Adam mowery and katharine mowery are spouses.”

Form 990, Part VI, Section B, Line 11B

“Form 990 draft was sent to the board for review and comments.”

Form 990, Part VI, Section C, Line 19

“AVAILABLE UPON REQUEST.”

Filing and Contact Details

Filer

Filer Name
International Foxp1 Foundation
EIN
85-4079051
Phone
7176486109
Address
PO BOX 846, MENDENHALL, PA 19357

Signing Officer

Name
Adam Mowery
Title
Treasurer
Phone
7176486109
Signed
2025-05-13
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Adam Mowery
Formed
2020
Legal Domicile
De
Voting Board Members
9
Independent Board Members
9
Employees
0
Volunteers
0

Preparer

Firm
Gunnip & Company Llp
Address
2751 CENTERVILLE RD STE 300, WILMINGTON, DE 19808
Preparer
Alex K Masciantonio CPA
Phone
3022255000
Raw XML AppendixShowing 400 of 420 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0SUPPORT THOSE IMPACTED BY FOXP1 SYNDROME AND RAISE FUNDS FOR FURTHER RESEARCH INTO FOXP1 SYNDROME AND POSSIBLE TREATMENTS.
IRS990/AdvertisingGrp/ManagementAndGeneralAmt03737
IRS990/AdvertisingGrp/TotalAmt03737
IRS990/AllOtherContributionsAmt0339208
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/BooksInCareOfDetail/PersonNm0ADAM MOWERY
IRS990/BooksInCareOfDetail/PhoneNum07176486109
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0PO BOX 846
IRS990/BooksInCareOfDetail/USAddress/CityNm0MENDENHALL
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0PA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd019357
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CapStkTrPrinCurrentFundsGrp/BOYAmt00
IRS990/CapStkTrPrinCurrentFundsGrp/EOYAmt00
IRS990/CashNonInterestBearingGrp/BOYAmt0171410
IRS990/CashNonInterestBearingGrp/EOYAmt0291034
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd00
IRS990/CompensationProcessOtherInd00
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt0507
IRS990/ConferencesMeetingsGrp/TotalAmt0507
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd00
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt0339208
IRS990/CYGrantsAndSimilarPaidAmt0185674
IRS990/CYInvestmentIncomeAmt0125
IRS990/CYOtherExpensesAmt043348
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0110311
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt0229022
IRS990/CYTotalFundraisingExpenseAmt05636
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt0339333
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DelegationOfMgmtDutiesInd00
IRS990/Desc0THREE-DIMENSIONAL ORGANOID MODEL OF FOXP1 SYNDROME-THE ULTIMATE GOAL OF THIS PROJECT IS TO DEVELOP AN IN VITRO MEDIUM-TO-HIGH THROUGHPUT ASSAY FOR SCREENING OF COMPOUND LIBRARIES. THE "HITS" FROM SUCH A SCREEN WILL BE DEFINED AS COMPOUNDS THAT "NORMALIZE" THE FOXP1 ORGANOID PHENOTYPE IN A DOSE-DEPENDENT MANNER. WHILE THERE IS NO OBVIOUS MECHANISTIC OR FUNCTIONAL LINK BETWEEN THE ORGANOID PHENOTYPE AND THE CLINICAL PRESENTATIONS, IT IS REASONABLE TO ASSUME THAT CHANGES IN ORGANOID DEVELOPMENT REFLECT CHANGES IN BRAIN DEVELOPMENT AND THAT UTILIZING ORGANOID PHENOTYPES VALIDATED IN PATIENT-DERIVED CELL LINES CARRYING CLINICALLY-RELEVANT MUTATIONS WILL ENSURE IDENTIFICATION OF POTENTIAL DRUG CANDIDATES. THIS APPROACH IS IN LINE WITH THE CURRENT INDUSTRY STANDARDS FOR DEVELOPMENT OF THE HIGH-THROUGHPUT SCREENING ASSAYS. THESE DRUG CANDIDATES (HITS) WILL BE FURTHER VALIDATED IN A NUMBER OF IN VITRO AND IN VIVO ASSAYS TO VALIDATE PRECLINICAL EFFICACY AND PROVIDE MORE MECHANISTIC INSIGHT.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd00
IRS990/DonorAdvisedFundInd00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt050000
IRS990/FamilyOrBusinessRlnInd01
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt01740
IRS990/FeesForServicesAccountingGrp/TotalAmt01740
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt06783
IRS990/FeesForServicesOtherGrp/TotalAmt06783
IRS990/ForeignActivitiesInd01
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignGrantsGrp/ProgramServicesAmt062400
IRS990/ForeignGrantsGrp/TotalAmt062400
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt02.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt14.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt32.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt44.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt510.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt613.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt70.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt84.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OfficerInd3X
IRS990/Form990PartVIISectionAGrp/OfficerInd4X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/PersonNm0ADAM GELLER
IRS990/Form990PartVIISectionAGrp/PersonNm1KARL WHITNEY
IRS990/Form990PartVIISectionAGrp/PersonNm2KATHARINE MOWERY
IRS990/Form990PartVIISectionAGrp/PersonNm3ADAM MOWERY
IRS990/Form990PartVIISectionAGrp/PersonNm4CHRIS SULLIVAN
IRS990/Form990PartVIISectionAGrp/PersonNm5GAIL CLARK
IRS990/Form990PartVIISectionAGrp/PersonNm6SAMIT DASGUPTA
IRS990/Form990PartVIISectionAGrp/PersonNm7CAROLINE DURY
IRS990/Form990PartVIISectionAGrp/PersonNm8CHERYL RICHT
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/TitleTxt0CO-FOUNDER & CO-PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt1CO-FOUNDER & CO-PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt2VICE PRESIDENT
IRS990/Form990PartVIISectionAGrp/TitleTxt3TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt4SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt5MEMBER AT LARGE
IRS990/Form990PartVIISectionAGrp/TitleTxt6MEMBER AT LARGE
IRS990/Form990PartVIISectionAGrp/TitleTxt7MEMBER AT LARGE
IRS990/Form990PartVIISectionAGrp/TitleTxt8MEMBER AT LARGE
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02020
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedInd00
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/SecuritiesAmt0125
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt09
IRS990/GrantAmt050000
IRS990/GrantsToDomesticOrgsGrp/ProgramServicesAmt0123274
IRS990/GrantsToDomesticOrgsGrp/TotalAmt0123274
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd01
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt010705
IRS990/GrossReceiptsAmt0349913
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd00
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt09
IRS990/IndivRcvdGreaterThan100KCnt00
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InsuranceGrp/ManagementAndGeneralAmt01253
IRS990/InsuranceGrp/TotalAmt01253
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LegalDomicileStateCd0DE
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt010580
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd00
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingCashInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0SUPPORT THOSE IMPACTED BY FOXP1 SYNDROME AND RAISE FUNDS FOR FURTHER RESEARCH INTO FOXP1 SYNDROME AND POSSIBLE TREATMENTS.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd01
IRS990/NetAssetsOrFundBalancesBOYAmt0171410
IRS990/NetAssetsOrFundBalancesEOYAmt0291034
IRS990/NetGainOrLossInvestmentsGrp/RelatedOrExemptFuncIncomeAmt0125
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0125
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NoncashContributionsAmt010580
IRS990/NondeductibleContributionsInd00
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0381
IRS990/OfficeExpensesGrp/TotalAmt0381
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrgDoesNotFollowFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt00
IRS990/OtherExpensesGrp/Desc0FUNDRAISER
IRS990/OtherExpensesGrp/Desc1BANK CHARGES
IRS990/OtherExpensesGrp/Desc2POSTAGE
IRS990/OtherExpensesGrp/Desc3OTHER
IRS990/OtherExpensesGrp/FundraisingAmt05636
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt02377
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt11372
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt274
IRS990/OtherExpensesGrp/TotalAmt05636
IRS990/OtherExpensesGrp/TotalAmt12377
IRS990/OtherExpensesGrp/TotalAmt21372
IRS990/OtherExpensesGrp/TotalAmt374
IRS990/PartialLiquidationInd00
IRS990/PdInCapSrplsLandBldgEqpFundGrp/BOYAmt00
IRS990/PdInCapSrplsLandBldgEqpFundGrp/EOYAmt00
IRS990/PoliticalCampaignActyInd00
IRS990/PrincipalOfficerNm0ADAM MOWERY
IRS990/PriorPeriodAdjustmentsAmt09313
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0FUNCTIONAL RESTORATION OF FOXP1 HAPLOINSUFFICIENCY USING AAV-MEDIATED GENE RESCUE IN THE BRAIN-UNDERSTANDING FOXP1 FUNCTION IN THE MOUSE BRAIN IS CRUCIAL TO DEVELOP EFFECTIVE THERAPEUTICS FOR FOXP1 SYNDROME IN HUMANS. IN THIS PROJECT, WE WILL USE A MOUSE MODEL THAT MIMICS THE GENETIC BASIS OF MANY FORMS OF FOXP1 SYNDROME, WHERE ONLY ONE OUT OF THE TWO FUNCTIONAL COPIES OF FOXP1 GENE IS PRESENT. WE WILL PERFORM INTRACEREBROVENTRICULAR (ICV) INJECTIONS OF A UNIQUE ADENO ASSOCIATED VIRUS (AAV) CALLED AAV9 AND/OR ITS MODIFIED AND IMPROVISED VERSION (AAV-PHP.EB) AT AN EARLY DEVELOPMENTAL STAGE TO RESTORE FOXP1 EXPRESSION IN THE BRAINS OF THESE MICE. IN THIS STRATEGY, FOXP1 WILL BE RE-EXPRESSED UNDER THE CONTROL OF THE HUMAN SYNAPSIN 1 PROMOTER, ENSURING NEURON SPECIFIC EXPRESSION. WE WILL THEN EXAMINE WHETHER FOXP1 GENE REPLACEMENT CAN CORRECT BEHAVIORAL DEFICITS IN THE MICE. IF SUCCESSFUL, WE WILL EXTEND THE GENE RESTORATION TO LATER DEVELOPMENTAL TIME POINTS TO DETERMINE A POTENTIAL CRITICAL WINDOW OF GENE REPLACEMENT THERAPY IN THIS MOUSE MODEL. RESULTS FROM THIS PROJECT SHOULD PROVIDE FUNDAMENTAL KNOWLEDGE ABOUT THE FEASIBILITY OF FOXP1 GENE THERAPY IN HUMANS AND FORM THE BASIS FOR FUTURE CLINICAL TRIALS.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt073274
IRS990/ProgSrvcAccomActy2Grp/GrantAmt073274
IRS990/ProgSrvcAccomActy3Grp/Desc0TESTING A POTENTIAL TREATMENT FOR FOXP1 SYNDROME IN STRIATAL ORGANOIDS DERIVED FROM INDIVIDUALS WITH PATHOGENIC FOXP1 VARIANTS -DR. FRHLICH AND PROF. RAPPOLD AT THE INSTITUTE OF HUMAN GENETICS IN HEIDELBERG, GERMANY HAVE DISCOVERED THAT MURINE FOXP1 HAPLOINSUFFICIENCY LEADS TO MITOCHONDRIAL DYSFUNCTION IN THE STRIATUM AND ALTERED EXPRESSION OF STRIATUM-SPECIFIC PHOSPHODIESTERASE 10A (PDE10A), AN ENZYME THAT PLAYS A CRUCIAL ROLE IN THE REGULATION OF BASAL GANGLIA CIRCUITS. SPECIFIC INHIBITION OF PDE10A WITH MP-10 SIGNIFICANTLY IMPROVED THE EXISTING BEHAVIORAL DEFICITS IN THESE ANIMALS. WORKING WITH ORGANOIDS HAS SIGNIFICANT IMPLICATIONS FOR A SAFE AND HUMANE TESTING OF NEW DRUGS, PARTICULARLY WHEN ORGANOIDS ARE GROWN FROM A PATIENT'S OWN CELLS. IN THE PLANNED PROJECT, IPSC LINES DERIVED FROM FOXP1 PATIENT AND CONTROL CELLS WILL BE USED AND DIFFERENTIATED INTO STRIATAL ORGANOIDS TO INVESTIGATE WHETHER MITOCHONDRIAL DYSFUNCTION AND PDE10A DYSREGULATION CAN ALSO BE FOUND IN HUMAN CELLS. IN ADDITION, IT WILL BE ANALYZED HOW THE ADMINISTRATION OF MP-10 AFFECTS GENE EXPRESSION AND SIGNALING PATHWAYS IN STRIATAL MEDIUM SPINY NEURONS AND WHETHER THE DRUG IMPROVES MITOCHONDRIAL FUNCTION.
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt062400
IRS990/ProgSrvcAccomActy3Grp/GrantAmt062400
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt00
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt00
IRS990/PYInvestmentIncomeAmt00
IRS990/PYOtherExpensesAmt00
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt00
IRS990/PYSalariesCompEmpBnftPaidAmt00
IRS990/PYTotalExpensesAmt00
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt00
IRS990/QuidProQuoContributionsInd00
IRS990/ReconcilationRevenueExpnssAmt0110311
IRS990/RegularMonitoringEnfrcInd00
IRS990/RelatedEntityInd00
IRS990/RelatedOrganizationCtrlEntInd00
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd00
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd00
IRS990/RtnEarnEndowmentIncmOthFndsGrp/BOYAmt0171410
IRS990/RtnEarnEndowmentIncmOthFndsGrp/EOYAmt0291034
IRS990ScheduleA/AmountsRcvdDsqlfyPersonGrp/TotalAmt00
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt0349217
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt0145384
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt071764
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt06760
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0573125
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt0125
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt0125
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt0125
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt0125
IRS990ScheduleA/InvestmentIncomeCYPct00.00020
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.99980
IRS990ScheduleA/PublicSupportPY509Pct01.00000
IRS990ScheduleA/PublicSupportTotal509Amt0573125
IRS990ScheduleA/SubstAndDsqlfyPrsnsTotGrp/TotalAmt00
IRS990ScheduleA/SubstantialContributorsAmtGrp/TotalAmt00
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt0349217
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt0145384
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt071764
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt06760
IRS990ScheduleA/Total509Grp/TotalAmt0573125
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt0349342
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt0145384
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt071764
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt06760
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0573250
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/EmployeeCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/OfficesCnt00
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTotalExpendituresAmt062400
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/RegionTxt0EUROPE (INCLUDING ICELAND & GREENLAND)
IRS990ScheduleF/AccountActivitiesOutsideUSGrp/TypeOfActivitiesConductedTxt0GRANT TO RECIPIENTS LOCATED IN THE REGION
IRS990ScheduleF/BoycottCountriesInd00
IRS990ScheduleF/ContinuationSpentAmt00
IRS990ScheduleF/ContinuationTotalEmployeeCnt00
IRS990ScheduleF/ContinuationTotalOfficeCnt00
IRS990ScheduleF/ForeignCorpOwnershipInd00
IRS990ScheduleF/ForeignPartnershipInd00
IRS990ScheduleF/GrantRecordsMaintainedInd01
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/CashGrantAmt062400
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/MannerOfCashDisbursementTxt0ELECTRONIC FUNDS TRANSFER
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/NonCashAssistanceAmt00
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/PurposeOfGrantTxt0TESTING A POTENTIAL TREATMENT FOR FOXP1 SYNDROME IN STRIATAL ORGANOIDS DERIVED FROM INDIVIDUALS WITH PATHOGENIC FOXP1 VARIANTS
IRS990ScheduleF/GrantsToOrgOutsideUSGrp/RegionTxt0EUROPE
IRS990ScheduleF/InterestInForeignTrustInd00
IRS990ScheduleF/PassiveForeignInvestmestCoInd00
IRS990ScheduleF/SubtotalEmployeesCnt00
IRS990ScheduleF/SubtotalOfficesCnt00
IRS990ScheduleF/SubtotalSpentAmt062400
IRS990ScheduleF/Total501c3OrgCnt01
IRS990ScheduleF/TotalEmployeeCnt00
IRS990ScheduleF/TotalOfficeCnt00
IRS990ScheduleF/TotalSpentAmt062400
IRS990ScheduleF/TransferToForeignCorpInd00
IRS990ScheduleI/GrantRecordsMaintainedInd01
IRS990ScheduleI/RecipientTable/CashGrantAmt050000
IRS990ScheduleI/RecipientTable/CashGrantAmt173274
IRS990ScheduleI/RecipientTable/IRCSectionDesc0501(C)(3)
IRS990ScheduleI/RecipientTable/IRCSectionDesc1501(C)(3)
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt00
IRS990ScheduleI/RecipientTable/NonCashAssistanceAmt10
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt0RESEARCH ON THREE-DIMENSIONAL ORGANOID MODEL OF FOXP1 SYNDROME
IRS990ScheduleI/RecipientTable/PurposeOfGrantTxt1RESEARCH ON FUNCTIONAL RESTORATION OF FOXP1 HAPLOINSUFFICIENCY USING AAV-MEDIATED GENE RESCUE IN THE BRAIN
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt0JOSEPH BUXBAUM SEAVER AUTISM INSTITUTE MT SINAI HOSPITAL
IRS990ScheduleI/RecipientTable/RecipientBusinessName/BusinessNameLine1Txt1GENEVIEVE KONOPKA AND JAY GIBSON UT SOUTHWESTERN MED CENTER
IRS990ScheduleI/RecipientTable/RecipientEIN0136171197
IRS990ScheduleI/RecipientTable/RecipientEIN1756002868
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt0ONE GUSTAVE L LEVY PLACE BOX 1049
IRS990ScheduleI/RecipientTable/USAddress/AddressLine1Txt15323 HARRY HINES BLVD
IRS990ScheduleI/RecipientTable/USAddress/CityNm0NEW YORK
IRS990ScheduleI/RecipientTable/USAddress/CityNm1DALLAS
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd0NY
IRS990ScheduleI/RecipientTable/USAddress/StateAbbreviationCd1TX
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd010029
IRS990ScheduleI/RecipientTable/USAddress/ZIPCd175390
IRS990/ScheduleJRequiredInd00
IRS990/ScheduleORequiredInd01
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0ADAM MOWERY AND KATHARINE MOWERY ARE SPOUSES.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1FORM 990 DRAFT WAS SENT TO THE BOARD FOR REVIEW AND COMMENTS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2AVAILABLE UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PART VI, SECTION A, LINE 2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PART VI, SECTION B, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PART VI, SECTION C, LINE 19
IRS990/SchoolOperatingInd00
IRS990/SignificantChangeInd00
IRS990/SignificantNewProgramSrvcInd00
IRS990/SubjectToExcsTaxNetInvstIncInd00
IRS990/SubjectToProxyTaxInd00
IRS990/SubjToTaxRmnrtnExPrchtPymtInd00
IRS990/TaxablePartyNotificationInd00
IRS990/TaxExemptBondsInd00
IRS990/TerminateOperationsInd00
IRS990/TotalAssetsBOYAmt0171410
IRS990/TotalAssetsEOYAmt0291034
IRS990/TotalAssetsGrp/BOYAmt0171410
IRS990/TotalAssetsGrp/EOYAmt0291034
IRS990/TotalCompGreaterThan150KInd00
IRS990/TotalContributionsAmt0339208
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt05636
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt037712
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0185674
IRS990/TotalFunctionalExpensesGrp/TotalAmt0229022
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt00
IRS990/TotalLiabilitiesEOYAmt00
IRS990/TotalLiabilitiesGrp/BOYAmt00
IRS990/TotalLiabilitiesGrp/EOYAmt00
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0171410
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0291034
IRS990/TotalOtherCompensationAmt00
IRS990/TotalProgramServiceExpensesAmt0185674
IRS990/TotalReportableCompFromOrgAmt00
IRS990/TotalRevenueGrp/ExclusionAmt00
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt0125
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt0339333
IRS990/TotalRevenueGrp/UnrelatedBusinessRevenueAmt00
IRS990/TotalVolunteersCnt00
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt0171410
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt0291034
IRS990/TotReportableCompRltdOrgAmt00
IRS990/TravelGrp/ManagementAndGeneralAmt019488
IRS990/TravelGrp/TotalAmt019488
IRS990/TrnsfrExmptNonChrtblRltdOrgInd00
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd00
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt0PO BOX 846
IRS990/USAddress/CityNm0MENDENHALL
IRS990/USAddress/StateAbbreviationCd0PA
IRS990/USAddress/ZIPCd019357
IRS990/VotingMembersGoverningBodyCnt09
IRS990/VotingMembersIndependentCnt09
IRS990/WebsiteAddressTxt0WWW.FOXP1.ORG
IRS990/WhistleblowerPolicyInd00
ReturnHeader/BuildTS02025-03-06 01:10:19Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd01
ReturnHeader/BusinessOfficerGrp/PersonNm0ADAM MOWERY
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0TREASURER
ReturnHeader/BusinessOfficerGrp/PhoneNum07176486109
ReturnHeader/BusinessOfficerGrp/SignatureDt02025-05-13
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0INTERNATIONAL FOXP1 FOUNDATION
ReturnHeader/Filer/BusinessNameControlTxt0INTE

Document Assets

No mirrored PDF or thumbnail assets are attached yet.